SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying as investors react to a strategic $14.2 billion deal to regain full ownership of its Ireland-based Fab 34, a move perceived as a major vote of confidence in the company's manufacturing and AI-driven growth trajectory. The community is actively debating the stock's future, with many interpreting the heavy capital reinvestment as a clear indicator that major new customer contracts are imminent.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the market reacts to the company's latest subscription price hikes, which analysts view as a strategic move to fund a massive content budget and solidify profitability. While some retail investors are voicing frustration over recurring cost increases, the community is heavily focused on the stock's relative strength and technical breakout potential, with many discussing its role as a hedge against broader market volatility.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is currently trending following news that it has secured FDA approval for VYKAT XR, the first therapy developed to treat hyperphagia in Prader-Willi syndrome. The community is actively discussing the stock's significant price momentum, debating the potential for a future acquisition by a larger pharmaceutical player, and evaluating the long-term commercial execution of this newly approved asset.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as shareholders analyze the strategic implications of parent company Centurium Capitals acquisition of Blue Bottle Coffee. While the community remains divided over potential conflicts of interest versus synergistic growth, investors are closely monitoring for signs of a long-anticipated U.S. exchange relisting and are actively debating the stock's future valuation amid shifting institutional ownership.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

The Next Bitcoin

Investors are rallying behind this Solana-based meme coin as a satirical movement intended to mock established market structures, with community members actively comparing its long-term potential to industry giants. Discussions are currently dominated by enthusiasts promoting the token's cultural narrative and its goal of creating viral engagement within the broader crypto ecosystem.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine Biosciences is trending as the market reacts to the definitive agreement to acquire Soleno Therapeutics for $2.9 billion. Community sentiment is mixed, with active debate regarding whether the acquisition effectively addresses Neurocrine's need for pipeline growth or if the premium paid for the rare-disease asset signals a strategic overpay.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines is experiencing a significant surge in momentum as the company reports positive trial results for its essential tremor and epilepsy therapies, driving multiple analyst price target upgrades. While the community is debating the impact of a recent large-scale public offering, many investors remain bullish on the long-term potential of the company's CNS-focused pipeline.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is seeing significant investor interest driven by a combination of resilient pricing power in its core smokeable business and ongoing momentum in its smoke-free portfolio, particularly with the growth of its on! nicotine pouches. The community is actively debating the company's long-term pivot from traditional cigarettes toward smoke-free alternatives, with many highlighting the stock's role as a classic, high-yield defensive play in a volatile market.

iShares Trust - iShares U.S. Transportation ETF

iShares Dow Jones Transportation Average

The iShares Dow Jones Transportation Average is experiencing significant volatility as investors debate the impact of rising fuel costs, labor disputes, and shifting freight demand on the broader economy. Market participants are closely watching the sector for signs of a potential recession or economic cooling, often using the ETF as a key indicator of market breadth and institutional sentiment.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as retail and institutional investors highlight increasing institutional accumulation and strategic partnerships in the AI infrastructure space, leading to significant options activity. Community members are actively debating the stock's long-term potential as a key player in 5G and 6G network deployment while monitoring its breakout above recent resistance levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?

Time to Load Up on Consumer Staples ETFs?

Volatility spikes, AI fatigue deepens and debt fears mount. Is it time to go defensive with consumer staples ETFs?

Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?

Can These 3 ETF Losers of 2025 Rebound in 2026?

Can beaten-down cloud ETFs like WCLD, staples ETF FXG, and India ETFs INCO & INQQ stage a rebound in 2026 after a mixed 2025?

Dollar Stores Top Mag-7 in 2025: Time for Value & Dividend ETFs?

Dollar stores are crushing the Mag-7 in 2025, signaling a shift to value. Is it time to look at RPV, RSPS, FLOW, MDPL and SDY?

Here's Why It's Time to Revisit Consumer Staples ETFs

Rising inflation and weakening sentiment are driving investors toward defensive consumer staple ETFs.

Analysts voiced skepticism over Target's choice of a two-decade company veteran as its next chief executive, warning that his appointment signals continuity rather than the sweeping changes the retailer needs to revive growth, particularly as tariff pressures mount.Is Michael Fiddelke, currently the chief operating officer, really an agent of change, argued DA Davidson, calling the move "catalyst lost." The research firm lowered its price target on the company's stock to $115 from $125, while maintaining its 'Buy' rating.Fiddelke, 49, will start in February next year and replace CEO Brian Cornel, who will retire. Fiddelke said on the earnings call that returning to growth would be his number one priority.Truist, which also lowered its price target while maintaining its 'Hold rating, stated that "substantial" investment changes, which Target needs to improve its long-term relevance, seem "less likely to occur under a long-time Target veteran."Jefferies lowered its price target by $5 and maintained its&nbsp;‘Buy’&nbsp;rating. Currently, 23 of the 37 analysts covering Target have a 'Hold' rating, nine rate it 'Buy' or higher, and four rate it 'strong sell,' according to Koyfin data. Their average price target is $102.68, just 4% below the last closing price.In recent years, Target has struggled to attract consumers and grow sales, losing its edge to discount retailers like Walmart and e-commerce companies. The Target brand had grown by offering fashionable items and slightly trendy everyday goods, which helped it differentiate. Now, even&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/target-faces-growth-challenges-as-staff-give-thumbs-down-to-management-efforts-report/chruFqaRdIR">employees say</a> the management is not doing enough to keep that up.A rebuke of gay Pride merchandise in 2023, as well as some Diversity, Equity, and Inclusion (DEI) policies earlier this year, have&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/target-stock-sinks-after-slashing-outlook-q1-earnings-miss/ch0edYhRbYL">hurt sales</a> and angered some investors and workers in recent quarters.The mood among retail investors, however, improved late Wednesday, especially after Target's upbeat quarterly report. In the second quarter, same-store sales fell less than feared, and overall revenue topped forecasts.On Stocktwits, the retail sentiment for Target climbed multiple notches higher in the 'extremely bullish' (91/100), with 'extremely high' message volume, as of late Wednesday.$TGT So we double beat, AND we got rid of that sh**ty DEI retard of a CEO and this goes down 10%?" a user posted. "Well all I can say is thank you to whoever sold me those shares this morning."<stembedurl>https://stocktwits.com/OnlyBuysDips/message/626008801</stembedurl><a href="https://stocktwits.com/symbol/TGT">Target shares</a> are down 27% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Customers enter and exit a Target store on November 20, 2024 in Austin, Texas. (Photo by Brandon Bell/Getty Images)

Agent For Change? Wall Street Questions Target Veteran Fiddelke's Appointment As CEO Over Doubts About Transformational Changes

Retail investors, however, took a bullish view after the big box retailer's upbeat quarterly report.

Wall Street Questions Target Veteran Fiddelke's Appointment As CEO Over Doubts About Transformational Changes

Equity

Retail investors, however, took a bullish view after the big box retailer's upbeat quarterly report.


Tough Road Ahead for U.S. Consumers? ETFs to Consider

Consumer confidence slips amid tariff fears and debt worries, boosting the case for consumer staples ETFs.

Constellation Brands (STZ) reported first-quarter results below Wall Street expectations on Wednesday. However, some positive comments on tariff headwind mitigation and an unchanged full-year outlook lifted shares.<a href="https://stocktwits.com/symbol/STZ">Constellation stock</a> gained 4.5% to $173.87, its best intraday gains in nearly three months. Shares are down 21.3% year-to-date.CEO Bill Newlands said Constellation "continued to face softer consumer demand largely driven by what we believe to be non-structural socioeconomic factors.Earlier this week, Bank of America&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bof-a-downgrades-miller-lite-brewer-molson-coors-amid-softness-in-us-beer-sales/chmZESFRReS">downgraded</a> peer Molson Coors Beverage's (TAP) shares, stating that it expects U.S. beer volumes to shrink by 4% next year, a steeper decline than its earlier prediction of a 1% decrease.Q1 revenue at Constellation, known for Corona beer and Robert Mondavi wine, dropped 6% to $2.52 billion, slightly below analysts' expectations. Earnings per share were $3.22, also below the estimate.Management stated that the company anticipates an approximately $20 million impact from aluminum tariffs for the remainder of its fiscal year, down from its earlier expectation of $30 million. Despite that, the company expects to maintain its targeted margin growth.On Stocktwits, the retail sentiment for the company shifted to 'bullish' from 'extremely bullish' the previous day.<figure class="image"><img style="aspect-ratio:580/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_03_at_10_29_59_AM_png_4106cdf670.webp" alt="Screenshot 2025-07-03 at 10.29.59 AM.png" width="580" height="61"><figcaption>STZ sentiment and message volume as of July 2 | Source: Stocktwits</figcaption></figure>A user said, "The exuberance (in the stock) seems a bit irrational," and backed it&nbsp;up by saying the company faces "declining market share, declining sales, declining profit, 25% tariff on Mexican beer, customer base being deported."<stembedurl>https://stocktwits.com/SaltyNuts/message/619760718</stembedurl>Following the results, Bank of America maintained its 'Neutral' rating on&nbsp;STZ stock&nbsp;and raised the price target by $2 to $182.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bottles of Corona beer are displayed on a shelf at a BevMo store on January 05, 2024 in San Rafael, California. (Photo by Justin Sullivan/Getty Images)

Constellation Brands Share Rise Despite Weak Earnings: Retail Sentiment Drops

The brewer of Corona beer maintained its full-year financial outlook.

Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight Consumer Staples ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

RSPS
Invesco S&P 500 Equal Weight Consumer Staples ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest RSPS News

RSPSInvesco S&P 500 Equal Weight Consumer Staples ETF